At a glance

CLECELL is a healthcare company dedicated to diverse research projects using our versatile bioprinting platform.

The platform is created based on the mature bioprinting experience by Harvard Medical School and skillful 3D printing technology by itself.

Our current target research is about 3D artificial human skin developed by the bioprinting platform, and its ultimate goal is to discover novel therapy for skin disease and anti-aging cosmetics for customers. The skin model is able to provide researchers with uniform quality so that collection of the data for pre-clinical test becomes easier and new safe products are commercialized safely.

Furthermore, we strive to produce patient-specific cancer chemotherapy kit for patients with cancer in breast, skin, prostate , and others. By providing this bio-printed precision medicine kit, we hope the patients from all over the world can precisely have their prescription and reduce their pain during medical treatment period.